Welcome to the 14th edition of Tablets, a prescribing newsletter produced monthly by the Medicines Management team of Midlands and Lancashire CSU.
|
|
|
Recommendations
BLACK SILK garments (Dermasilk®, Dreamskin®, Skinnies Silk®)
The Pan Mersey Area Prescribing Committee does not recommend the prescribing of SILK garments (Dermasilk®, Dreamskin®, Skinnies Silk®) for eczema or atopic dermatitis.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS231.pdf
BLACK TAPENTADOL immediate release preparations (Palexia®) Static
The Pan Mersey Area Prescribing Committee does not recommend the prescribing of TAPENTADOL immediate release preparations (Palexia®) for pain relief.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS120.pdf
RED Abatacept infusion and subcutaneous injection (Orencia®) in rheumatological conditions
The Pan Mersey Area Prescribing Committee recommends the prescribing of abatacept infusion and subcutaneous injection (Orencia®) for rheumatoid arthritis and infusion for polyarticular juvenile idiopathic arthritis as described.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS133.pdf
RED ADALIMUMAB injection (Humira®) in rheumatological conditions
The Pan Mersey Area Prescribing Committee recommends the prescribing of adalimumab injection (Humira®) for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and in patients fitting other criteria commissioned by Pan Mersey CCGs, as described below.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS62.pdf
RED CERTOLIZUMAB injection (Cimzia®) in rheumatological conditions
The Pan Mersey Area Prescribing Committee recommends the prescribing of certolizumab injection (Cimzia®) for rheumatoid arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis and psoriatic arthritis, as well as in patients fitting other criteria commissioned by Pan Mersey CCGs, as listed.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS63.pdf
RED ETANERCEPT injection (including biosimilars) in rheumatological conditions
The Pan Mersey Area Prescribing Committee recommends the prescribing of etanercept injection for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and adult-onset Still’s disease, as well as in patients fitting other criteria commissioned by Pan Mersey CCGs, as listed below.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS64.pdf
RED GOLIMUMAB injection (Simponi®) in rheumatological conditions
The Pan Mersey Area Prescribing Committee recommends the prescribing of golimumab injection (Simponi®) for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and in patients fitting other criteria commissioned by Pan Mersey CCGs, as listed below.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS65.pdf
RED INFLIXIMAB infusion (including biosimilars) in rheumatological conditions
The Pan Mersey Area Prescribing Committee recommends the prescribing of infliximab infusion for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis and adult-onset Still’s disease, as well as in patients fitting other criteria commissioned by Pan Mersey CCGs, as listed below.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS66.pdf
RED TOCILIZUMAB (RoActemra®) in rheumatological conditions
The Pan Mersey Area Prescribing Committee recommends the prescribing of tocilizumab infusion and subcutaneous injection (RoActemra®) for the treatment of rheumatoid arthritis and adult-onset Still’s disease, and the infusion for juvenile idiopathic arthritis, as described below.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS135.pdf
AMBER ELUXADOLINE Tablets (Truberzi®▼)
The Pan Mersey Area Prescribing Committee recommends the prescribing of ELUXADOLINE Tablets (Truberzi®▼) following specialist initiation for irritable bowel syndrome with diarrhoea in adults in accordance with NICE TA471.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS200.pdf
GREEN FINASTERIDE 5mg tablets
The Pan Mersey Area Prescribing Committee recommends FINASTERIDE 5mg tablets as the 5-alpha reductase inhibitor of choice for men with lower urinary tract symptoms (LUTS) as detailed.
http://www.panmerseyapc.nhs.uk/recommendations/documents/PS36.pdf
Guidelines
Drugs for Dementia: Information for Primary Care
http://www.panmerseyapc.nhs.uk/guidelines/documents/G31_supporting_information.pdf
High Cost Drugs pathway
http://www.panmerseyapc.nhs.uk/guidelines/documents/G9.pdf
Shared Care
Mycophenolate mofetil
http://www.panmerseyapc.nhs.uk/shared_care/documents/SC22.pdf
Prescribing support
Mepacrine
http://www.panmerseyapc.nhs.uk/prescribing_support/documents/PSI9.pdf
|
|
NICE Guidance March 2018
The following guidelines have been published by the National Institute for Clinical Excellence in March 2018:
The Attention deficit hyperactivity disorder guideline has been published and replaces the 2008 guidance. The guideline aims to improve the recognition, diagnosis, support and management of attention deficit hyperactivity disorder (ADHD) in children, young people and adults.
The Heavy menstrual bleeding guideline has been published and replaces the 2007 guidance. The guideline covers the assessment and management of heavy menstrual bleeds (menorrhagia). The guidelines aim to help healthcare professionals investigate the cause of heavy periods that can affect a woman’s quality of life and to offer the right treatments.
It is vital clinicians are aware of these changes and implement any required changes to their practice.
CKS Updates March 2018
During the month of March 2018, the following Clinical Knowledge Summaries were updated:
The most significant change is to the topic on Gout which has been updated in line with national guidance. The alopecia areata and leg cramps topic have both been expanded.
|
|
Please click here for a summary of safety updates and SPC updates.
|
|
|
|